# Council Regulation (EU) No 557/2014 of 6 May 2014 establishing the Innovative Medicines Initiative 2 Joint Undertaking (Text with EEA relevance), Division 3: The States Representatives Group shall be consulted and, in particular, review information and provide opinions on the following matters:

Extent: E+W+S+N.I.

(a) programme progress of the IMI2 Joint Undertaking and achievement of its targets, including the information on calls and proposals evaluation process;
(b) updating of strategic orientation;
(c) links to Horizon 2020;
(d) annual work plans;
(e) involvement of SMEs.

---
Source: https://www.legislation.gov.uk/eur/2014/557/annex/division/11/division/3 (the official version)
Page: https://openlegislation.uk/eu-regulation-2014-557/annex/division-11/division-3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.